MicroRNA-196a increases apoptosis in B cells through downregulation of FOXO1
Soyoung Kim1, Mina Han1, Hyun Ju Hwang1
1Asan Institute for Life Sciences and Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract:
MicroRNAs (miRNAs) are key regulators of cancer pathogenesis, and their expression is often dysregulated in cancer cells. The role of miR-196a-5p has been investigated in various types of cancers. However, it is relatively less understood in B-cell malignancies. This study aimed to investigate the role of miR-196a-5p in B cells by using a human diffuse large B-cell lymphoma cell line, SU-DHL-6, and mouse B lymphocytes. The enforced expression of miR-196a in SU-DHL-6 cells increased daunorubicin-mediated apoptosis. Luciferase assay revealed that FOXO1 was a direct target of miR-196a-5p in SU-DHL-6 cells. The mRNA and protein expression of FOXO1 was downregulated in miR-196a-overexpressing SU-DHL-6 cells. In addition, miR-196a-5p was highly expressed in mouse bone marrow cells, compared with that of splenic B cells, and FOXO1 expression was negatively correlated with miR-196a-5p level. miR-196a-5p was upregulated by B-cell receptor stimulation, which was inversely correlated with FOXO1 expression in splenic B cells. Apoptosis was increased when miR-196a-5p was upregulated in murine primary B cells. These results identify miR-196a-5p as a post-transcriptional regulator of FOXO1 and indicate its importance in regulating B-cell malignancies and activation.
Insights
MicroRNA-196a-5p (miR-196a-5p) regulates B-cell malignancies by targeting FOXO1. Upregulating miR-196a-5p increases apoptosis in B cells, suggesting its therapeutic potential in B-cell cancers.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- MicroRNAs (miRNAs) are crucial in cancer development, with altered expression common in cancer cells.
- While miR-196a-5p's role is known in some cancers, its function in B-cell malignancies remains less explored.
- Understanding miRNA regulation is vital for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role and regulatory mechanisms of miR-196a-5p in B cells.
- To determine if miR-196a-5p influences B-cell lymphoma cell lines and primary B lymphocytes.
- To identify the downstream targets of miR-196a-5p in the context of B-cell activation and malignancy.
Main Methods:
- Utilized a human diffuse large B-cell lymphoma cell line (SU-DHL-6) and mouse B lymphocytes.
- Performed enforced expression of miR-196a in SU-DHL-6 cells to assess apoptosis.
- Conducted luciferase assays to identify direct targets of miR-196a-5p.
- Analyzed mRNA and protein expression levels of target genes.
- Investigated miR-196a-5p expression in different B-cell populations and its correlation with B-cell receptor stimulation.
Main Results:
- Enforced miR-196a expression enhanced daunorubicin-induced apoptosis in SU-DHL-6 cells.
- FOXO1 was identified as a direct target of miR-196a-5p, with its expression downregulated upon miR-196a-5p overexpression.
- miR-196a-5p was highly expressed in mouse bone marrow B cells compared to splenic B cells, showing an inverse correlation with FOXO1 levels.
- miR-196a-5p expression increased with B-cell receptor stimulation, inversely correlating with FOXO1.
- Upregulation of miR-196a-5p in primary murine B cells led to increased apoptosis.
Conclusions:
- miR-196a-5p acts as a post-transcriptional regulator of FOXO1.
- The findings highlight miR-196a-5p's significant role in regulating B-cell malignancies.
- miR-196a-5p is implicated in the activation and apoptosis of B cells, suggesting its potential as a therapeutic target.
Related Concept Videos
The Intrinsic Apoptotic Pathway
MicroRNAs
The Extrinsic Apoptotic Pathway
Apoptosis
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Experimental RNAi


